• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • Myinsights
  • MYBoard
  • Strategy & Consulting
Select Page

Teaching, Writing, Healing: The Intersections of My Cancer Journey

by MM360 Staff | May 24, 2025 | Uncategorized

Source: CureToday articles Fifteen years after being diagnosed with small lymphocytic lymphoma, I’ve found healing and meaning in the work I love and the life I’m grateful to live. Read More

True Grit: The Spirit of an Extraordinary Healer

by MM360 Staff | May 23, 2025 | Uncategorized

Source: CureToday articles Heather Patenaude, B.S.N., RN, displays the highest level of technical skills necessary to provide compassionate care to her patients. Read More

Uniting Pediatric and Adult Oncologists to Advance AYA Lymphoma Care

by MM360 Staff | May 23, 2025 | Uncategorized

Source: CureToday articles Dr. Andrew M. Evens discusses some of the recent research advancements in AYA lymphoma care that have emerged through clinical trials and initiatives. Read More

Physical Activity Can Improve Quality of Life in Patients With Newly Diagnosed Multiple Myeloma

by MM360 Staff | May 23, 2025 | Uncategorized

Source: Pharmacy Times articles Physical activity significantly enhanced quality of life and reduced fatigue and depression in patients with newly diagnosed multiple myeloma. Read More

Making Something Positive out of Breast Cancer

by MM360 Staff | May 23, 2025 | Uncategorized

Source: CureToday articles After my breast cancer treatment, I started a clothing bank to give others free access to recovery items like post-surgery shirts and pillows. Read More

Expert Offers Surveillance, Lifestyle Guidance After CRC, Anal Cancer

by MM360 Staff | May 22, 2025 | Uncategorized

Source: CureToday articles Avoiding smoking, eating a high-fiber diet and routine screenings are key to reducing the risk of recurrence in colorectal or anal cancer. Read More
« Older Entries
Next Entries »

Recent Content

  • Targeted Chemo Improves Survival in Early-Stage Lung Cancer
  • Utilizing AI in Prostate Cancer Care and Management
  • KITE-363 Shows High Response in B-Cell Lymphoma With Manageable Safety
  • Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations
  • Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation
  • Op-Ed: Expand Patient Choice to Lower Medication Costs
  • Sasanlimab-BCG Combo May Delay Recurrence in Bladder Cancer
  • Meta-Analysis Evaluates RSV Viral Load and Symptom Kinetics
  • Personalized Vaccine Elicits Responses in Patients With Kidney Cancer
  • SCIg More Effective Immunoglobulin Option for Immunocompromised Patients With Inborn Errors of Immunity
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT